Irena Royzman has joined the life sciences team at Orrick Herrington & Sutcliffe in New York, the firm said Monday.
Royzman’s experience includes litigation under the Hatch-Waxman Act and Biologics Price Competition and Innovation Act, according to Orrick. She has worked on cases involving small-molecule drugs, antibodies and other biologics, recombinant DNA technology, gene therapies, and medical devices.
She was the head of the life sciences practice at Kramer Levin.
This story was produced by Bloomberg Law Automation.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.